Adocia ACT revenue for the last year amounted to 2.30 M USD, the most of which — 2.32 M USD — came from its highest performing source at the moment, Pre-approved Therapeutic Proteins, the year earlier bringing 12.03 M USD. The greatest contribution to the revenue figure was made by France — last year it brought Adocia ACT 2.32 M USD, and the year before that — 12.03 M USD.